EUVIMEDEUVIMED entdecken
Crossref

Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments

Quentin Lefebvre, Raquel Mato, Colin Bournez

Synthesis · 15.11.2024 · 56 (22) · 3450-3458

DOI: 10.1055/s-0040-1720137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synthesis, erschienen am 15.11.2024. Verfasst von Quentin Lefebvre und 2 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Target-first drug discovery relies heavily on protein structure information, which severely limits its application. In recent years, fragment-based drug Design (FBDD) has been identified as an alternative solution, where screening of smaller molecules for lower affinity allowed the use of focused libraries with a higher hit rate. It is shown that coupling an sp2-rich heteroaromatic group with a monofunctional sp3-rich core gives fragments (186 examples) with advantageous physical-chemical properties, covering a chemical space often neglected in traditional libraries.

Zitieren

APA

Lefebvre, Q., Mato, R., & Bournez, C. (2024). Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments. Synthesis, 56(22), 3450-3458. https://doi.org/10.1055/s-0040-1720137

Vancouver

Lefebvre Q, Mato R, Bournez C. Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments. Synthesis. 2024;56(22):3450-3458. doi:10.1055/s-0040-1720137

BibTeX
@article{Lefebvre2024,
  author = {Lefebvre, Quentin and Mato, Raquel and Bournez, Colin},
  title = {Accessing a Medicinal-Chemistry-Relevant Chemical Space with sp2–sp3 Hybrid Heterocyclic Fragments},
  journal = {Synthesis},
  year = {2024},
  volume = {56},
  number = {22},
  pages = {3450--3458},
  doi = {10.1055/s-0040-1720137}
}
Kostenlos starten →